Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III rando... von Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

Volltext

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2- advanced breast cancer receiving first-line ribociclib plus fulvestrant von Neven, P, Fasching, P A, Chia, S, Jerusalem, G, De Laurentiis, M, Im, S-A, Petrakova, K, Bianchi, G V, Martín, M, Nusch, A, Sonke, G S, De la Cruz-Merino, L, Beck, J T, Zarate, J P, Wang, Y, Chakravartty, A, Wang, C, Slamon, D J

Volltext

Ageism and caring attitudes among nurses in oncology von Schroyen, S., Missotten, P., Jerusalem, G., Gilles, C., Adam, S.

Volltext

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Ass... von Plana, Juan Carlos, Galderisi, Maurizio, Barac, Ana, Ewer, Michael S, Ky, Bonnie, Scherrer-Crosbie, Marielle, Ganame, Javier, Sebag, Igal A, Agler, Deborah A, Badano, Luigi P, Banchs, Jose, Cardinale, Daniela, Carver, Joseph, Cerqueira, Manuel, DeCara, Jeanne M, Edvardsen, Thor, Flamm, Scott D, Force, Thomas, Griffin, Brian P, Jerusalem, Guy, Liu, Jennifer E, Magalhães, Andreia, Marwick, Thomas, Sanchez, Liza Y, Sicari, Rosa, Villarraga, Hector R, Lancellotti, Patrizio

Volltext

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aroma... von Jerusalem, G., Mariani, G., Ciruelos, E.M., Martin, M., Tjan-Heijnen, V.C.G., Neven, P., Gavila, J.G., Michelotti, A., Montemurro, F., Generali, D., Simoncini, E., Lang, I., Mardiak, J., Naume, B., Camozzi, M., Lorizzo, K., Bianchetti, S., Conte, P.

Volltext

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium von Kenis, C., Decoster, L., Flamaing, J., Debruyne, P.R., De Groof, I., Focan, C., Cornélis, F., Verschaeve, V., Bachmann, C., Bron, D., Luce, S., Debugne, G., Van den Bulck, H., Goeminne, J.-C., Schrijvers, D., Geboers, K., Petit, B., Langenaeken, C., Van Rijswijk, R., Specenier, P., Jerusalem, G., Praet, J.-P., Vandenborre, K., Lobelle, J.-P., Lycke, M., Milisen, K., Wildiers, H.

Volltext

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy von Pistilli, B., Pluard, T., Urruticoechea, A., Farci, D., Kong, A., Bachelot, T., Chan, S., Han, H. S., Jerusalem, G., Urban, P., Robinson, D., Mouhaër, S. L., Tomaso, E. D., Massacesi, C., Saura, C.

Volltext

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy von Jerusalem, G., Farah, S., Courtois, A., Chirgwin, J., Aebi, S., Karlsson, P., Neven, P., Hitre, E., Graas, M.P., Simoncini, E., Abdi, E., Kamby, C., Thompson, A., Loibl, S., Gavilá, J., Kuroi, K., Marth, C., Müller, B., O’Reilly, S., Gombos, A., Ruhstaller, T., Burstein, H.J., Rabaglio, M., Ruepp, B., Ribi, K., Viale, G., Gelber, R.D., Coates, A.S., Loi, S., Goldhirsch, A., Regan, M.M., Colleoni, M.

Volltext

Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in p... von Grégoire, C., Faymonville, M.-E., Vanhaudenhuyse, A., Jerusalem, G., Willems, S., Bragard, I.

Volltext

Recurrent or primary metastatic cervical cancer: current and future treatments von Gennigens, C., Jerusalem, G., Lapaille, L., De Cuypere, M., Streel, S., Kridelka, F., Ray-Coquard, I.

Volltext

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised... von Bonnefoi, H., Jacot, W., Saghatchian, M., Moldovan, C., Venat-Bouvet, L., Zaman, K., Matos, E., Petit, T., Bodmer, A., Quenel-Tueux, N., Chakiba, C., Vuylsteke, P., Jerusalem, G., Brain, E., Tredan, O., Messina, C.G.M., Slaets, L., Cameron, D.

Volltext

Corrigendum to ‘Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the... von Slamon, D.J., Neven, P., Chia, S., Jerusalem, G., De Laurentiis, M., Im, S., Petrakova, K., Valeria Bianchi, G., Martín, M., Nusch, A., Sonke, G.S., De la Cruz-Merino, L., Beck, J.T., Ji, Y., Wang, C., Deore, U., Chakravartty, A., Zarate, J.P., Taran, T., Fasching, P.A.

Volltext

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery von Quinten, C., Kenis, C., Decoster, L., Debruyne, P. R., De Groof, I., Focan, C., Cornelis, F., Verschaeve, V., Bachmann, C., Bron, D., Luce, S., Debugne, G., Van den Bulck, H., Goeminne, J. C., Baitar, A., Geboers, K., Petit, B., Langenaeken, C., Van Rijswijk, R., Specenier, P., Jerusalem, G., Praet, J. P., Vandenborre, K., Lycke, M., Flamaing, J., Milisen, K., Lobelle, J. P., Wildiers, H.

Volltext

Communication of healthcare professionals: Is there ageism? von Schroyen, S., Adam, S., Marquet, M., Jerusalem, G., Thiel, S., Giraudet, A.‐L., Missotten, P.

Volltext

Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome von Onesti, C.E., Boemer, F., Josse, C., Leduc, S., Poulet, C., Bours, V., Jerusalem, G.

Volltext

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/B... von Gennari, A., Sun, Z., Hasler-Strub, U., Colleoni, M., Kennedy, M.J., Von Moos, R., Cortés, J., Vidal, M.J., Hennessy, B., Walshe, J., Parraga, K. Amillano, Ribi, K., Bernhard, J., Murillo, S. Morales, Pagani, O., Barbeaux, A., Borstnar, S., Rabaglio-Poretti, M., Maibach, R., Regan, M.M., Jerusalem, G.

Volltext

EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the... von Lancellotti, Patrizio, Anker, Stefan D, Donal, Erwan, Edvardsen, Thor, Popescu, Bogdan A, Farmakis, Dimitrios, Filippatos, Gerasimos, Habib, Gilbert, Maggioni, Aldo P, Jerusalem, Guy, Galderisi, Maurizio

Volltext

Ribociclib (RIB) + fulvestrant (FUL) in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-3 biomark... von Neven, P., Petrakova, K., Bianchi, G.V., De La Cruz Merino, L., Jerusalem, G., Beck, J.T., Sonke, G.S., Chia, S., Brucker, S., Wang, Y., He, W., Rodriguez Lorenc, K., Su, F., Im, S.-A.

Volltext

Ribociclib (RIB) + fulvestrant (FUL) for advanced breast cancer (ABC): Progression-free survival (PFS) subgroup and tumor response analyses from MONALEESA-3 von Jerusalem, G., Fasching, P.A., Martín, M., Pivot, X., Petrakova, K., Bianchi, G.V., Nusch, A., Sonke, G.S., De La Cruz Merino, L., Vagnon, E., Alam, J., Kong, O., Chandiwana, D., De Laurentiis, M.

Volltext

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer von Capri, G., Chang, J., Chen, S.-C., Conte, P., Cwiertka, K., Jerusalem, G., Jiang, Z., Johnston, S., Kaufman, B., Link, J., Ro, J., Schütte, J., Oliva, C., Parikh, R., Preston, A., Rosenlund, J., Selzer, M., Zembryki, D., De Placido, S.

Volltext